Aflibercept-related sterile inflammation.
Publication
, Journal Article
Hahn, P; Kim, JE; Stinnett, S; Chung, MM; Dugel, PU; Flynn, HW; Huang, SS; Sadda, SR; Mahmoud, TH ...
Published in: Ophthalmology
May 2013
Duke Scholars
Published In
Ophthalmology
DOI
EISSN
1549-4713
Publication Date
May 2013
Volume
120
Issue
5
Start / End Page
1100-101.e1-5
Location
United States
Related Subject Headings
- Uveitis
- Recombinant Fusion Proteins
- Receptors, Vascular Endothelial Growth Factor
- Ophthalmology & Optometry
- Middle Aged
- Male
- Macular Degeneration
- Injections, Intraocular
- Humans
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Hahn, P., Kim, J. E., Stinnett, S., Chung, M. M., Dugel, P. U., Flynn, H. W., … American Society of Retina Specialists Therapeutic Surveillance Committee, . (2013). Aflibercept-related sterile inflammation. Ophthalmology, 120(5), 1100-101.e1-5. https://doi.org/10.1016/j.ophtha.2012.11.018
Hahn, Paul, Judy E. Kim, Sandra Stinnett, Mina M. Chung, Pravin U. Dugel, Harry W. Flynn, Suber S. Huang, Srinivas R. Sadda, Tamer H. Mahmoud, and Tamer H. American Society of Retina Specialists Therapeutic Surveillance Committee. “Aflibercept-related sterile inflammation.” Ophthalmology 120, no. 5 (May 2013): 1100-101.e1-5. https://doi.org/10.1016/j.ophtha.2012.11.018.
Hahn P, Kim JE, Stinnett S, Chung MM, Dugel PU, Flynn HW, et al. Aflibercept-related sterile inflammation. Ophthalmology. 2013 May;120(5):1100-101.e1-5.
Hahn, Paul, et al. “Aflibercept-related sterile inflammation.” Ophthalmology, vol. 120, no. 5, May 2013, pp. 1100-101.e1-5. Pubmed, doi:10.1016/j.ophtha.2012.11.018.
Hahn P, Kim JE, Stinnett S, Chung MM, Dugel PU, Flynn HW, Huang SS, Sadda SR, Mahmoud TH, American Society of Retina Specialists Therapeutic Surveillance Committee. Aflibercept-related sterile inflammation. Ophthalmology. 2013 May;120(5):1100-101.e1–5.
Published In
Ophthalmology
DOI
EISSN
1549-4713
Publication Date
May 2013
Volume
120
Issue
5
Start / End Page
1100-101.e1-5
Location
United States
Related Subject Headings
- Uveitis
- Recombinant Fusion Proteins
- Receptors, Vascular Endothelial Growth Factor
- Ophthalmology & Optometry
- Middle Aged
- Male
- Macular Degeneration
- Injections, Intraocular
- Humans
- Female